Blocking protein could halt debilitating brain diseaseApril 30th, 2012 - 1:16 pm ICT by IANS
Sydney, April 30 (IANS) Blocking a protein that contributes to acute nerve damage could halt the development of debilitating Multiple Sclerosis (MS), says a new study.
Some of MS symptoms are blurred vision, eye ache, blindness, partial or mild paralysis, jerking and twitching muscles, tingling, buzzing and vibration sensations, male and female impotence, irregular bowel movements, swallowing problems, etc.
MS is estimated to affect up to 2.5 million people worldwide. The disease tends to strike early in adulthood, with women three times more likely than men to be diagnosed for it, the journal Brain reported.
Scientists from the Monash University’s Immunology and Stem Cell Lab (MISCL), Universities of Toronto, Yale and Western Australia, have demonstrated the key role played by the collapsin response mediator protein 2 (CRMP-2) in the development of MS.
Led by reserachers Steven Petratos from MISCL and Claude Bernard, the research team found that a modified version of CRMP-2 is present in active MS lesions, which indicate damage to the nervous system, in a lab model of MS, said a university statement.
The modified CRMP-2 interacts with another protein to cause nerve fibre damage that can result in numbness, blindness, difficulties with speech and motor skills, and cognitive impairments in sufferers.
When either the modified CRMP-2 or the interaction between the two proteins was blocked, the progression of the disease was halted.
Richard Boyd, director MISCL, said the discovery could lead to new treatments for MS, “Blocking the same protein in people with MS could provide a ‘handbrake’ to the progression of the disease.”
Petratos said the method used to block the protein was approved for the treatment of other disease conditions by both the US Food and Drug Administration and Australia’s Therapeutic Goods Administration.
“This should mean that clinical trials - once they start - will be fast tracked as the form of administration has already been approved,” Petratos said.
- Protein pathway find may help solve Parkinson's disease - Mar 01, 2011
- Re-engineered toxins can treat asthma, arthritis - Jan 02, 2012
- Optogenetics used to effectively stimulate muscle movement in mice - Sep 27, 2010
- Scientists discover new target for multiple sclerosis - Oct 26, 2010
- Protein key to storing long-term memories - Jan 29, 2012
- Can traumatic memories be erased? - Apr 28, 2011
- New method to help nerves grow after trauma or injury found - Jul 13, 2010
- A breakthrough in Alzhemier's or Parkinson's treatment? - May 07, 2012
- New mouse model to probe how antidepressants work - Feb 19, 2011
- New study offers hope to those with multiple sclerosis - Feb 24, 2011
- How plants fight diseases - Mar 29, 2011
- New mice study offers hope in the fight against Alzheimer's - Dec 04, 2010
- Scientists block multiple sclerosis in mouse model - Mar 08, 2011
- Stem cells could cure 'silent thief of sight' - Mar 12, 2011
- 'Master switch' that triggers arthritis identified - Jan 17, 2011
Tags: brain disease, claude bernard, cognitive impairments, crmp, eye ache, female impotence, food and drug administration, irregular bowel movements, lab model, monash university, ms lesions, ms symptoms, nerve damage, nerve fibre, richard boyd, swallowing problems, therapeutic goods administration, twitching muscles, universities of toronto, us food and drug administration